LLY

1,108.92

+3.86%↑

JNJ

206.8

+0.38%↑

ABBV

231.86

+1.03%↑

UNH

326.26

+2.45%↑

AZN

93.26

+1.86%↑

LLY

1,108.92

+3.86%↑

JNJ

206.8

+0.38%↑

ABBV

231.86

+1.03%↑

UNH

326.26

+2.45%↑

AZN

93.26

+1.86%↑

LLY

1,108.92

+3.86%↑

JNJ

206.8

+0.38%↑

ABBV

231.86

+1.03%↑

UNH

326.26

+2.45%↑

AZN

93.26

+1.86%↑

LLY

1,108.92

+3.86%↑

JNJ

206.8

+0.38%↑

ABBV

231.86

+1.03%↑

UNH

326.26

+2.45%↑

AZN

93.26

+1.86%↑

LLY

1,108.92

+3.86%↑

JNJ

206.8

+0.38%↑

ABBV

231.86

+1.03%↑

UNH

326.26

+2.45%↑

AZN

93.26

+1.86%↑

Search

Kala Pharmaceuticals Inc

Closed

0.61

Overview

Share price change

24h

Current

Min

0.52

Max

0.63

Key metrics

By Trading Economics

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+141.94% upside

Kala Pharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

24 Nov 2025, 21:54 UTC

Acquisitions, Mergers, Takeovers

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175 Million

24 Nov 2025, 18:26 UTC

Major Market Movers

Tegna Shares Fall After Trump Blasts Proposal to Lift Broadcast Ownership Cap

24 Nov 2025, 23:49 UTC

Market Talk

Nikkei May Rise After Tech Recovery on Wall Street -- Market Talk

24 Nov 2025, 23:08 UTC

Market Talk

More Losses Ahead for Steel & Tube, Says New Bear -- Market Talk

24 Nov 2025, 23:08 UTC

Market Talk

Global Equities Roundup: Market Talk

24 Nov 2025, 22:56 UTC

Market Talk
Earnings

Alimentation Couche-Tard U.S. Sales Gain Momentum -- Market Talk

24 Nov 2025, 22:47 UTC

Market Talk

Kiwi Property Can Keep Growing Its Dividend -- Market Talk

24 Nov 2025, 22:36 UTC

Market Talk
Earnings

Kiwi Property's 1H Result Cements Bull's Confidence in Outlook -- Market Talk

24 Nov 2025, 22:32 UTC

Earnings

Webco Industries 1Q EPS $6.79 >WEBC

24 Nov 2025, 22:07 UTC

Earnings

Couche-Tard 2Q Canada Same-Store Merchandise Revenues Up 5.4% >ATD.T

24 Nov 2025, 22:07 UTC

Earnings

Couche-Tard 2Q U.S. Same-Store Merchandise Revenues Up 1.2% >ATD.T

24 Nov 2025, 22:06 UTC

Earnings

Couche-Tard 2Q Adj EPS 78c >ATD.T

24 Nov 2025, 22:06 UTC

Earnings

Couche-Tard 2Q Rev $17.9B >ATD.T

24 Nov 2025, 22:06 UTC

Earnings

Couche-Tard 2Q EPS 79c >ATD.T

24 Nov 2025, 22:05 UTC

Earnings

Couche-Tard 2Q Rev $17.9B >ATD.T

24 Nov 2025, 22:05 UTC

Earnings

Couche-Tard 2Q Net $740.6M >ATD.T

24 Nov 2025, 22:05 UTC

Earnings

Couche-Tard 2Q Adj EPS 78c >ATD.T

24 Nov 2025, 22:05 UTC

Earnings

Couche-Tard 2Q EPS 79c >ATD.T

24 Nov 2025, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Basic Materials Roundup: Market Talk

24 Nov 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

24 Nov 2025, 21:44 UTC

Market Talk

Canada Close to MOU With Alberta About New Possible Pipeline -- Market Talk

24 Nov 2025, 21:39 UTC

Acquisitions, Mergers, Takeovers

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175M

24 Nov 2025, 20:42 UTC

Market Talk

Oil Futures Snap Three-Session Losing Streak -- Market Talk

24 Nov 2025, 20:41 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

24 Nov 2025, 19:56 UTC

Acquisitions, Mergers, Takeovers

Nvidia Says It's Not Enron in Private Memo Refuting Accounting Questions -- Barrons.com

24 Nov 2025, 18:26 UTC

Market Talk

Crude Futures Move Higher in Choppy Trade -- Market Talk

24 Nov 2025, 17:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Basic Materials Roundup: Market Talk

24 Nov 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

24 Nov 2025, 17:09 UTC

Market Talk

Brent Could Drop to the $30s Without Production Cuts, JPM Says -- Market Talk

24 Nov 2025, 16:52 UTC

Acquisitions, Mergers, Takeovers

Strategy Silent on Bitcoin Holdings. Why It's a Big Deal for the Stock and Cryptos. -- Barrons.com

Peer Comparison

Price change

Kala Pharmaceuticals Inc Forecast

Price Target

By TipRanks

141.94% upside

12 Months Forecast

Average 1.5 USD  141.94%

High 1.5 USD

Low 1.5 USD

Based on 2 Wall Street analysts offering 12 month price targets forKala Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

2 ratings

0

Buy

2

Hold

0

Sell

Financials

$

About Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc
help-icon Live chat